Abbvie (ABBV) Stock Price

Statistics

The AbbVie, Inc. stock price is closed at $ 215.70 with a total market cap valuation of $ 381.10B(1.77B shares outstanding). The AbbVie, Inc. is trading on New York Stock Exchange with the sign ABBV. AbbVie, Inc. price is up 0.56% in the past 24 hours. The AbbVie, Inc. stock price prediction is currently bullish. The AbbVie, Inc. trailing twelve month dividend rate is $ 5.63 per share with dividend yield of 0.04%.

You can buy AbbVie, Inc. (ABBV) stock on eToro. For more information check our how to buy AbbVie, Inc. (ABBV) stock guide.

Description

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Company Profile

• Full Name: AbbVie, Inc.
• CEO: Richard A. Gonzalez
• Total Employees: 30,000
• Sector: Health Technology
• Industry: Pharmaceuticals: Major
• Country: US
• Address: 1 North Waukegan Road , North Chicago, IL60064-6400
• Website:http://www.abbvie.com
• Phone: 1-847-932-7900